Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Murray

Showing results (71-80 of 183) with videos related to

Pageof 19
Sort By:
The Journal of Antimicrobial Chemotherapy|September 1, 1994
In-vitro activity of OPC-17116 against bacterial enteric pathogensR C Arduino, M Frosolono, B E Murray
Antimicrobial Agents and Chemotherapy|September 1, 1994
Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalisV Korten, W M Huang, B E Murray
Diagnostic Microbiology and Infectious Disease|September 1, 1994
DU-6859a, a new fluoroquinolone agent. Comparative in vitro activity against enteric pathogens and multiresistant outpatient Escherichia coliJ F Tomayko, V Korten, B E Murray
Antimicrobial Agents and Chemotherapy|November 16, 2001
In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocciK V Singh, K Malathum, B E Murray
Journal of Clinical Microbiology|June 1, 1993
Comparison of ribotyping and pulsed-field gel electrophoresis for subspecies differentiation of strains of Enterococcus faecalisM E Gordillo, K V Singh, B E Murray
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 24, 2010
Management of multidrug-resistant enterococcal infectionsC A Arias, G A Contreras, B E Murray
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococciT M Coque, R C Arduino, B E Murray
Antimicrobial Agents and Chemotherapy|September 1, 1996
In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organismsK V Singh, T M Coque, B E Murray
Antimicrobial Agents and Chemotherapy|September 1, 1991
Lack of homology of enterococci which have high-level resistance to trimethoprim with the dfrA gene of Staphylococcus aureusM Frosolono, S L Hodel-Christian, B E Murray
Antimicrobial Agents and Chemotherapy|November 18, 2000
Efficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis modelK V Singh, K K Zscheck, B E Murray
Pageof 19

Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
The Journal of Antimicrobial Chemotherapy|September 1, 1994
In-vitro activity of OPC-17116 against bacterial enteric pathogensR C Arduino, M Frosolono, B E Murray
Antimicrobial Agents and Chemotherapy|September 1, 1994
Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalisV Korten, W M Huang, B E Murray
Diagnostic Microbiology and Infectious Disease|September 1, 1994
DU-6859a, a new fluoroquinolone agent. Comparative in vitro activity against enteric pathogens and multiresistant outpatient Escherichia coliJ F Tomayko, V Korten, B E Murray
Antimicrobial Agents and Chemotherapy|November 16, 2001
In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocciK V Singh, K Malathum, B E Murray
Journal of Clinical Microbiology|June 1, 1993
Comparison of ribotyping and pulsed-field gel electrophoresis for subspecies differentiation of strains of Enterococcus faecalisM E Gordillo, K V Singh, B E Murray
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 24, 2010
Management of multidrug-resistant enterococcal infectionsC A Arias, G A Contreras, B E Murray
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococciT M Coque, R C Arduino, B E Murray
Antimicrobial Agents and Chemotherapy|September 1, 1996
In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organismsK V Singh, T M Coque, B E Murray
Antimicrobial Agents and Chemotherapy|September 1, 1991
Lack of homology of enterococci which have high-level resistance to trimethoprim with the dfrA gene of Staphylococcus aureusM Frosolono, S L Hodel-Christian, B E Murray
Antimicrobial Agents and Chemotherapy|November 18, 2000
Efficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis modelK V Singh, K K Zscheck, B E Murray
Pageof 19